Delcath Systems, Inc. DCTH
Set alert
As of Nov 3, 2:52 PM ET
- YTD
- +42.77%
- 1 year
- +51.47%
- Open
- 14.25
- Prev close
- 14.29
- Mkt cap
- 500.01M
- Vol
- 209.83K
- Avg vol
- 460.82K
- EPS
- 0.01
- P/E
- 1441.00
- Div yield
- 0.00%
More statistics
- Low
- 14.20
- High
- 14.52
- Forward P/E
- -35.75
- Beta
- 0.76
- Short ratio
- 5.26
- Inst. own
- 38.13%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 10.72
- 200-d avg
- 8.12
- 1y target
- 21.33
5D chart
Signals (82)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:10 PM | 4 days ago |
| SMA: Bullish | Oct 30, 3:00 PM | 4 days ago |
| RSI: Oversold | Oct 30, 2:30 PM | 4 days ago |
| SMA: Bullish | Oct 30, 1:55 PM | 4 days ago |
| RSI: Oversold | Oct 30, 1:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 30, 1:00 PM | 4 days ago |
| MACD: Sell Signal | Oct 30, 12:45 PM | 4 days ago |
| RSI: Oversold | Oct 30, 12:40 PM | 4 days ago |
| MACD: Buy Signal | Oct 30, 12:20 PM | 4 days ago |
| MACD: Sell Signal | Oct 30, 11:35 AM | 4 days ago |
| SMA: Bullish | Oct 30, 10:55 AM | 4 days ago |
| MACD: Buy Signal | Oct 30, 10:50 AM | 4 days ago |
| MACD: Sell Signal | Oct 30, 9:45 AM | 4 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 4 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 4 days ago |
| SMA: Bullish | Oct 30, 9:35 AM | 4 days ago |
| SMA: Bullish | Oct 30, 9:35 AM | 4 days ago |
| MACD: Buy Signal | Oct 30, 9:35 AM | 4 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 4 days ago |
Newest 20 of 82.
News
1 week ago businesswire.com
Delcath Systems to Participate in Upcoming Investor Conferences
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced…
1 week ago businesswire.com
Delcath Systems to Host Third Quarter 2026 Earnings Call
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it…
-
2 weeks ago benzinga.com
Delcath Systems Presents Data Regarding Its Clinical Development Programs At European Society For Medical Oncology Congress 2026; Presents Publication Of Analysis Of Percutaneous Hepatic Perfusion With Melphalan Using CHEMOSAT Hepatic Delivery Systems
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced presentations related to its clinical…
2 weeks ago businesswire.com
Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced…
4 weeks ago benzinga.com
Delcath Systems Q2 2026 Earnings Call Transcript
Delcath Systems (NASDAQ:DCTH) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide…
1 month ago defenseworld.net
Analysts Set Delcath Systems, Inc. (NASDAQ:DCTH) PT at $23.17
Shares of Delcath Systems, Inc. (NASDAQ: DCTH - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the firm,…
1 month ago zacks.com
Are Medical Stocks Lagging Delcath Systems (DCTH) This Year?
Here is how Delcath Systems, Inc. (DCTH) and Encompass Health (EHC) have performed compared to their sector so far this year.
1 month ago businesswire.com
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of…
1 month ago zacks.com
Keep Portfolio Volatility in Check With VLO, PBF, FET & DCTH
VLO, PBF, FET and DCTH screen as low-beta picks as volatility rises, backed by refining, energy-equipment and liver-cancer growth drivers.
2 months ago zacks.com
5 Stocks With Recent Price Strength Buoyed by a Strong August
EDRY, RCMT, ASMB, DCTH and NESR show strong recent price momentum after a strong August, backed by improving earnings expectations.
2 months ago businesswire.com
Delcath Systems to Participate in Upcoming Investor Conferences
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced…
2 months ago zacks.com
What Makes Delcath Systems, Inc. (DCTH) a Strong Momentum Stock: Buy Now?
Does Delcath Systems, Inc. (DCTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
2 months ago zacks.com
Recent Price Trend in Delcath Systems (DCTH) is Your Friend, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Delcath Systems (DCTH) could be a great choice. It is one of the several stocks that passed through our…
2 months ago zacks.com
Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 52.44%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 52.4% in Delcath Systems (DCTH). While the effectiveness of this highly sought-after metric is questionable,…
2 months ago zacks.com
Delcath Systems (DCTH) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Delcath Systems (DCTH) could be a great choice. It is one of the several stocks that passed through our…
2 months ago zacks.com
Here's Why Delcath Systems, Inc. (DCTH) is a Great Momentum Stock to Buy
Does Delcath Systems, Inc. (DCTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
2 months ago zacks.com
Does Delcath Systems (DCTH) Have the Potential to Rally 42.77% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 42.8% in Delcath Systems (DCTH). While the effectiveness of this highly sought-after metric is questionable,…
-
2 months ago benzinga.com
HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $32
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Delcath Systems (NASDAQ:DCTH) with a Buy and raises the price target from $30 to $32.
2 months ago seekingalpha.com
Delcath Systems, Inc. (DCTH) Q2 2026 Earnings Call Transcript
Delcath Systems, Inc. (DCTH) Q2 2026 Earnings Call Transcript
-
2 months ago benzinga.com
BTIG Maintains Buy on Delcath Systems, Raises Price Target to $21
BTIG analyst Marie Thibault maintains Delcath Systems (NASDAQ:DCTH) with a Buy and raises the price target from $17 to $21.
2 months ago marketbeat.com
Delcath Systems Q2 Earnings Call Highlights
Delcath Systems NASDAQ: DCTH reported second-quarter 2026 revenue of $29.1 million, up from $24.2 million a year earlier, as growth in HEPZATO KIT sales supported continued commercial expansion and…
2 months ago zacks.com
Delcath Systems, Inc. (DCTH) Tops Q2 Earnings and Revenue Estimates
Delcath Systems, Inc. (DCTH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.16 per share. This compares to earnings of $0.07 per share a…
-
2 months ago benzinga.com
Delcath Systems Q2 EPS $0.07 Beats $(0.09) Estimate, Sales $29.133M Beat $26.259M Estimate
Delcath Systems (NASDAQ:DCTH) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.09) by 177.78 percent. This is unchanged from the same period last year.…
-
2 months ago benzinga.com
Delcath Systems Sees FY2026 Sales $104.000M-$108.000M vs $103.242M Est
Delcath Systems (NASDAQ:DCTH) sees FY2026 sales of $104.000 million-$108.000 million vs $103.242 million analyst estimate.
2 months ago businesswire.com
Delcath Systems Reports Second Quarter 2026 Results and Business Highlights
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced financial…
3 months ago businesswire.com
Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced…
-
6 months ago benzinga.com
Delcath Systems Q1 EPS $(0.03) Beats $(0.10) Estimate, Sales $24.994M Beat $23.383M Estimate
Delcath Systems (NASDAQ:DCTH) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.10) by 70 percent. This is a 200 percent decrease over earnings of $0.03…
-
7 months ago benzinga.com
Delcath Systems' CHEMOSAT M-PHP Recognized As Recommended Liver-Directed Therapy For Metastatic Uveal Melanoma In 2026 ESMO–EURACAN Guidelines
Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on liver-directed cancer therapies, today announced that its proprietary CHEMOSAT® Hepatic Delivery System for…
-
8 months ago benzinga.com
BTIG Maintains Buy on Delcath Systems, Lowers Price Target to $19
BTIG analyst Marie Thibault maintains Delcath Systems (NASDAQ:DCTH) with a Buy and lowers the price target from $23 to $19.
-
8 months ago benzinga.com
Delcath Systems FY2026 Total CHEMOSAT and HEPZATO KIT Revenue expected to be more than $100.000M vs $112.895M Est
Delcath Systems (NASDAQ:DCTH) FY2026 Total CHEMOSAT and HEPZATO KIT Revenue expected to be more than $100.000M vs $112.895M Est
-
8 months ago benzinga.com
Delcath Systems Q4 EPS $(0.05) Beats $(0.06) Estimate, Sales $20.728M Beat $20.326M Estimate
Delcath Systems (NASDAQ:DCTH) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 19.35 percent. This is a 54.55 percent increase over losses of…
8 months ago benzinga.com
Delcath Systems Q4 Earnings Assessment
Delcath Systems Q4 Earnings Assessment
8 months ago benzinga.com
Earnings Scheduled For February 26, 2026
Earnings Scheduled For February 26, 2026
-
9 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Delcath Systems, Maintains $30 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Delcath Systems (NASDAQ:DCTH) with a Buy and maintains $30 price target.
11 months ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today's Session
10 Health Care Stocks With Whale Alerts In Today's Session
12 months ago benzinga.com
Earnings Scheduled For November 4, 2025
Earnings Scheduled For November 4, 2025
1 year ago benzinga.com
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
1 year ago benzinga.com
Tesla To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Friday
Tesla To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Friday
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
1 year ago benzinga.com
Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
-
1 year ago benzinga.com
MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Thursday.
-
1 year ago benzinga.com
Why Zoomcar Shares Are Trading Higher By Around 142%; Here Are 20 Stocks Moving Premarket
Why Zoomcar Shares Are Trading Higher By Around 142%; Here Are 20 Stocks Moving Premarket
-
2 years ago benzinga.com
Wall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday?
Wall Street is experiencing a subdued trading session, with all major indices showing minimal movement around midday in New York.
-
2 years ago benzinga.com
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
-
2 years ago benzinga.com
Earnings Scheduled For March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
-
2 years ago benzinga.com
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
-
3 years ago benzinga.com
Nasdaq Falls 100 Points; Siyata Mobile Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 100 points on Tuesday. The Dow traded down 0.82% to 35,017.95 while the NASDAQ fell 0.77% to 13,682.54. The…